您当前的位置:
首页 >
文章列表页 >
Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials
REVIEW | 更新时间:2025-12-13
    • Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials

    • Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials

    • “在癌症三阴性治疗领域,近年来的研究取得了重大进展。专家们已经证实,靶向酪氨酸激酶(TKs)及其受体可以提供对抗TNBC的解决方案,为构建精准医学系统奠定了基础。”
    • Kasshish Mehta ,Mangala Hegde ,Sosmitha Girisa ,Ravichandran Vishwa ,Mohammed S. Alqahtani ,Mohamed Abbas ,Mehdi Shakibaei ,Gautam Sethi ,Ajaikumar B. Kunnumakkara
    • MMR 2025年12卷第8期 页码:1258-1282
    • DOI: 10.1186/s40779-024-00582-z     

      中图分类号:
    • 录用:2024-11-08 ,

    移动端阅览

  •  
  •  
  • AI导读

  • HTML全文

  • 图( 4 ) 表( 3 )

  • 参考文献

  • 出版信息

  • 数据统计

52

浏览量

40

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Glycosylation as a design component of biomaterials in implant design
Toward phase contribution assessment in perioperative oncology: insights from NSCLC and a proposal for broader implementation
Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

相关作者

Ajaikumar B. Kunnumakkara
Gautam Sethi
Abhay Pandit
Ning Li
Da-Wei Wu
Ning Jiang
Yu Tang
Yan-Jie Han

相关机构

Rinn Medical Devices, University of Galway
Department of Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Health Management Center, the First Affiliated Hospital of Zhengzhou University
Shanghai Mobio Biomedical Technology Co., Ltd
Department of Breast Surgery, Affiliated Cancer Hospital of Zhengzhou University